![Yi-Wu Vincent Xie](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yi-Wu Vincent Xie
Keine laufenden Positionen mehr
Profil
Yi-Wu Vincent Xie served as the Chief Technology Officer at China Biologic Products, Inc. before obtaining a doctorate degree from New York Medical College and an undergraduate degree from Sun Yat-Sen University.
Ehemalige bekannte Positionen von Yi-Wu Vincent Xie
Unternehmen | Position | Ende |
---|---|---|
China Biologic Products, Inc.
![]() China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Yi-Wu Vincent Xie
Sun Yat-Sen University | Undergraduate Degree |
New York Medical College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
China Biologic Products, Inc.
![]() China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Health Technology |